210 related articles for article (PubMed ID: 19608702)
1. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.
Di Marco GS; Reuter S; Hillebrand U; Amler S; König M; Larger E; Oberleithner H; Brand E; Pavenstädt H; Brand M
J Am Soc Nephrol; 2009 Oct; 20(10):2235-45. PubMed ID: 19608702
[TBL] [Abstract][Full Text] [Related]
2. The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy.
Zhai Y; Liu Y; Qi Y; Long X; Gao J; Yao X; Chen Y; Wang X; Lu S; Zhao Z
PLoS One; 2020; 15(8):e0234492. PubMed ID: 32790760
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia.
Zhou Q; Qiao FY; Zhao C; Liu HY
Cell Biol Int; 2011 Jan; 35(1):61-6. PubMed ID: 20828367
[TBL] [Abstract][Full Text] [Related]
4. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Imagawa K; Nishida T; Morikawa Y; Takemoto Y; Asai O; Soeda T; Okayama S; Ishigami K; Nakatani K; Kawata H; Horii M; Nakajima T; Akai Y; Iwano M; Saito Y
Circulation; 2009 Dec; 120(24):2470-7. PubMed ID: 19948974
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
[TBL] [Abstract][Full Text] [Related]
6. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
7. Soluble Flt-1 links microvascular disease with heart failure in CKD.
Di Marco GS; Kentrup D; Reuter S; Mayer AB; Golle L; Tiemann K; Fobker M; Engelbertz C; Breithardt G; Brand E; Reinecke H; Pavenstädt H; Brand M
Basic Res Cardiol; 2015 May; 110(3):30. PubMed ID: 25893874
[TBL] [Abstract][Full Text] [Related]
8. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.
Sugimoto H; Hamano Y; Charytan D; Cosgrove D; Kieran M; Sudhakar A; Kalluri R
J Biol Chem; 2003 Apr; 278(15):12605-8. PubMed ID: 12538598
[TBL] [Abstract][Full Text] [Related]
10. Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1.
Lavainne F; Meffray E; Pepper RJ; Néel M; Delcroix C; Salama AD; Fakhouri F
Nephrol Dial Transplant; 2014 Jun; 29(6):1225-31. PubMed ID: 24516233
[TBL] [Abstract][Full Text] [Related]
11. Damage of the endothelial glycocalyx in chronic kidney disease.
Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P
Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235
[TBL] [Abstract][Full Text] [Related]
12. The Soluble Fms-like Tyrosine Kinase-1 Contributes to Structural and Functional Changes in Endothelial Cells in Chronic Kidney Disease.
Schulz A; Drost CC; Hesse B; Beul K; Brand M; Di Marco GS
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555698
[TBL] [Abstract][Full Text] [Related]
13. Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.
Tantawy AAG; Adly AAM; Ismail EAR; Youssef OI; Ali ME
Clin Appl Thromb Hemost; 2017 Nov; 23(8):943-950. PubMed ID: 28301910
[TBL] [Abstract][Full Text] [Related]
14. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
[TBL] [Abstract][Full Text] [Related]
15. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
Felmeden DC; Spencer CG; Belgore FM; Blann AD; Beevers DG; Lip GY
Am J Hypertens; 2003 Jan; 16(1):11-20. PubMed ID: 12517677
[TBL] [Abstract][Full Text] [Related]
16. Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease.
Ataga KI; Brittain JE; Jones SK; May R; Delaney J; Strayhorn D; Desai P; Redding-Lallinger R; Key NS; Orringer EP
Br J Haematol; 2011 Feb; 152(4):485-91. PubMed ID: 21223248
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats.
Bridges JP; Gilbert JS; Colson D; Gilbert SA; Dukes MP; Ryan MJ; Granger JP
Am J Hypertens; 2009 May; 22(5):564-8. PubMed ID: 19265787
[TBL] [Abstract][Full Text] [Related]
18. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
Belgore FM; Blann AD; Lip GY
Clin Sci (Lond); 2001 May; 100(5):567-75. PubMed ID: 11294698
[TBL] [Abstract][Full Text] [Related]
19. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.
Chung NA; Lydakis C; Belgore F; Li-Saw-Hee FL; Blann AD; Lip GY
Heart; 2003 Dec; 89(12):1411-5. PubMed ID: 14617549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
